Bodi B, Vago R, Nagy L, Raduly A, Gulyas A, Kupecz K
Int J Mol Sci. 2025; 26(5).
PMID: 40076880
PMC: 11900185.
DOI: 10.3390/ijms26052259.
Amador-Martinez I, Aparicio-Trejo O, Bernabe-Yepes B, Aranda-Rivera A, Cruz-Gregorio A, Sanchez-Lozada L
Int J Mol Sci. 2023; 24(21).
PMID: 37958859
PMC: 10650149.
DOI: 10.3390/ijms242115875.
Vyletelova V, Novakova M, Paskova L
Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297390
PMC: 9611871.
DOI: 10.3390/ph15101278.
Kumar S, Pollok R, Goldsmith D
Inflamm Bowel Dis. 2022; 29(8):1306-1316.
PMID: 35942657
PMC: 10393213.
DOI: 10.1093/ibd/izac140.
Kim H, Kim S, Song S
Korean J Intern Med. 2022; 37(3):502-519.
PMID: 35368179
PMC: 9082447.
DOI: 10.3904/kjim.2021.515.
A Consistency Model for Identifying the Effects of n-3 and n-6 Fatty Acids on Lipoproteins in Dialysis Patients.
Chang K, Chen Y, Yeh S, Kao C, Cheng C, Kang Y
Nutrients. 2022; 14(6).
PMID: 35334907
PMC: 8954007.
DOI: 10.3390/nu14061250.
Prognosis and risk factors for cardiac valve calcification in Chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration.
Xiong J, Chen X, Liang C, Guo W, Wu B, Du X
Ren Fail. 2022; 44(1):224-232.
PMID: 35166181
PMC: 8856035.
DOI: 10.1080/0886022X.2022.2032742.
Ischemic preconditioning protects the heart against ischemia-reperfusion injury in chronic kidney disease in both males and females.
Sarkozy M, Marvanykovi F, Szucs G, Kovacs Z, Szabo M, Gaspar R
Biol Sex Differ. 2021; 12(1):49.
PMID: 34488888
PMC: 8420010.
DOI: 10.1186/s13293-021-00392-1.
Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy.
Kovacs Z, Szucs G, Freiwan M, Kovacs M, Marvanykovi F, Dinh H
Sci Rep. 2021; 11(1):17495.
PMID: 34471171
PMC: 8410807.
DOI: 10.1038/s41598-021-96815-5.
Endogenous estrogen exposure and chronic kidney disease; a 15-year prospective cohort study.
Farahmand M, Ramezani Tehrani F, Khalili D, Cheraghi L, Azizi F
BMC Endocr Disord. 2021; 21(1):155.
PMID: 34348694
PMC: 8336110.
DOI: 10.1186/s12902-021-00817-3.
Whole-Mount Kidney Clearing and Visualization Reveal Renal Sympathetic Hyperinnervation in Heart Failure Mice.
Wu C, Yan F, Li M, Tu Y, Guo Z, Chen Y
Front Physiol. 2021; 12:696286.
PMID: 34305650
PMC: 8297621.
DOI: 10.3389/fphys.2021.696286.
Immunohistochemistry of Kidney a-SMA, Collagen 1, and Collagen 3, in A Novel Mouse Model of Reno-cardiac Syndrome.
Kieswich J, Chen J, Alliouachene S, Caton P, McCafferty K, Thiemermann C
Bio Protoc. 2021; 10(18):e3751.
PMID: 33659410
PMC: 7842416.
DOI: 10.21769/BioProtoc.3751.
Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy.
Magnocavallo M, Bellasi A, Mariani M, Fusaro M, Ravera M, Paoletti E
J Clin Med. 2020; 10(1).
PMID: 33379379
PMC: 7796391.
DOI: 10.3390/jcm10010083.
Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature.
Savira F, Magaye R, Liew D, Reid C, Kelly D, Kompa A
Br J Pharmacol. 2020; 177(13):2906-2922.
PMID: 32250449
PMC: 7280015.
DOI: 10.1111/bph.15065.
Clinical and functional patient characteristics predict medical needs in older patients at risk of functional decline.
Scharf A, Gronewold J, Dahlmann C, Schlitzer J, Kribben A, Gerken G
BMC Geriatr. 2020; 20(1):75.
PMID: 32085737
PMC: 7035632.
DOI: 10.1186/s12877-020-1443-1.
Health outcome of older hospitalized patients in internal medicine environments evaluated by Identification of Seniors at Risk (ISAR) screening and geriatric assessment.
Scharf A, Gronewold J, Dahlmann C, Schlitzer J, Kribben A, Gerken G
BMC Geriatr. 2019; 19(1):221.
PMID: 31412787
PMC: 6694685.
DOI: 10.1186/s12877-019-1239-3.
Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212.
Sarkozy M, Gaspar R, Zvara A, Siska A, Kovari B, Szucs G
Sci Rep. 2019; 9(1):1302.
PMID: 30718600
PMC: 6362219.
DOI: 10.1038/s41598-018-37690-5.
Potential Role of H-Ferritin in Mitigating Valvular Mineralization.
Sikura K, Potor L, Szerafin T, Zarjou A, Agarwal A, Arosio P
Arterioscler Thromb Vasc Biol. 2019; 39(3):413-431.
PMID: 30700131
PMC: 6393195.
DOI: 10.1161/ATVBAHA.118.312191.
Mechanisms and Modulation of Oxidative/Nitrative Stress in Type 4 Cardio-Renal Syndrome and Renal Sarcopenia.
Sarkozy M, Kovacs Z, Kovacs M, Gaspar R, Szucs G, Dux L
Front Physiol. 2018; 9:1648.
PMID: 30534079
PMC: 6275322.
DOI: 10.3389/fphys.2018.01648.
A novel model of reno-cardiac syndrome in the C57BL/ 6 mouse strain.
Kieswich J, Chen J, Alliouachene S, Caton P, McCafferty K, Thiemermann C
BMC Nephrol. 2018; 19(1):346.
PMID: 30509210
PMC: 6278034.
DOI: 10.1186/s12882-018-1155-3.